Transient “rest” induces functional reinvigoration and epigenetic remodeling in exhausted CAR-T cells
Open accessAbstract
SUMMARY: T cell exhaustion limits immune responses against cancer and is a major cause of resistance to CAR-T cell therapeutics. Using a model wherein tonic CAR signaling induces hallmark features of exhaustion, we employed a drug-regulatable CAR to test the impact of transient cessation of receptor signaling (i.e. “rest”) on the development and maintenance of exhaustion. Induction of rest in exhausting or already-exhausted CAR-T cells resulted in acquisition of a memory-like phenotype, improved anti-tumor functionality, and wholescale transcriptional and epigenetic reprogramming. Similar results were achieved with the Src kinase inhibitor dasatinib, which reversibly suppresses CAR signaling. The degree of functional reinvigoration was proportional to the duration of rest and was associated with expression of transcription factors TCF1 and LEF1. This work demonstrates that transient cessation of CAR-T cell signaling can enhance anti-tumor potency by preventing or reversing exhaustion and challenges the paradigm that exhaustion is an epigenetically fixed state.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A thalidomide analogue-inducible dimerization domain has been generated from a fragment of CRBN and a zinc finger with all lysines substituted to arginines (K0), and split CARs have been built that require drug treatment for dimerization and subsequent activation.
“Furthermore, a thalidomide analogue-inducible dimerization domain has been generated from a fragment of CRBN and a zinc finger with all lysines substituted to arginines (K0), and with this system split CARs have been built that require drug treatment for dimerization and subsequent activation207.”
From Cancer therapies based on targeted protein degradation — lessons learned with lenalidomide (2021) · cites this paper as [207]
'Super-degron' tags composed of hybrid zinc finger degrons have been engineered to enhance the efficiency of drug-mediated degradation.
“To further develop this concept, ‘super-degron’ tags composed of hybrid zinc finger degrons have been engineered to enhance the efficiency of drug-mediated degradation117,207.”
From Cancer therapies based on targeted protein degradation — lessons learned with lenalidomide (2021) · cites this paper as [207]
Super-degron tags have been incorporated into thalidomide analogue-mediated off-switch CARs, which can be degraded and functionally inhibited at sub-therapeutic drug concentrations.
“These super-degron tags have been incorporated into thalidomide analogue-mediated off-switch CARs, which can be degraded and thus functionally inhibited at sub-therapeutic drug concentrations (FIG. 4)207.”
From Cancer therapies based on targeted protein degradation — lessons learned with lenalidomide (2021) · cites this paper as [207]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106 · see citing works
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625 · cited 1× · see citing works
“Gene set enrichment analysis was performed using the GSEA software (Broad Institute) as described (Mootha et al., 2003; Subramanian et al., 2005).”
MethodMootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197 · cited 1× · see citing works
“Gene set enrichment analysis was performed using the GSEA software (Broad Institute) as described (Mootha et al., 2003; Subramanian et al., 2005).”
MethodNear-optimal probabilistic RNA-seq quantification
Bray, N. L., Pimentel, H., Melsted, P., & Pachter, L. (2016) · Nature Biotechnology · doi:10.1038/nbt.3519 · Cited by 9,723 · cited 2× · see citing works
“44) (Bray et al., 2016) index against hg38 reference genome.”
MethodInfluentialCancer immunotherapy using checkpoint blockade
Ribas, A., & Wolchok, J. D. (2018) · Science · doi:10.1126/science.aar4060 · Cited by 6,791 · cited 2× · see citing works
“PD-1 blockade can reinvigorate exhausted T cells (Barber et al., 2006) and therapeutic agents targeting the PD-1/PD-L1 axis have improved outcomes for many patients with cancer, but durable anti-tumor effects occur in only a fraction of those treated (Ribas and Wolchok, 2018).”
BackgroundBuenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y., & Greenleaf, W. J. (2013) · Nature Methods · doi:10.1038/nmeth.2688 · Cited by 6,422 · cited 11× · see citing works
“ATAC-seq CAR-T cells were sorted on CD8 (see Cell Sorting) and processed for ATAC-seq, which was carried out as previously reported (Corces et al., 2017).”
MethodInfluentialSelf-citationChimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Maude, S. L., Frey, N., Shaw, P. A., Aplenc, R., Barrett, D. M., Bunin, N. J., Chew, A., Gonzalez, V. E., Zheng, Z., Lacey, S. F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407222 · Cited by 5,413 · cited 2× · see citing works
“CAR-T cells mediate high response rates in relapsed/refractory high-grade B cell malignancies, but less than 50% of patients experience long-term disease control and CAR-T cells have not demonstrated reproducible efficacy against solid tumors (Davila et al., 2014; Lee et al., 2015; Majzner and Mackall, 2019; Maude et…”
BackgroundRestoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2005) · Nature · doi:10.1038/nature04444 · Cited by 3,960 · cited 1× · see citing works
“PD-1 blockade can reinvigorate exhausted T cells (Barber et al., 2006) and therapeutic agents targeting the PD-1/PD-L1 axis have improved outcomes for many patients with cancer, but durable anti-tumor effects occur in only a fraction of those treated (Ribas and Wolchok, 2018).”
BackgroundLee, D. W., Kochenderfer, J. N., Stetler-Stevenson, M., Cui, Y. K., Delbrook, C., Feldman, S. A., Fry, T. J., Orentas, R., Sabatino, M., Shah, N. N., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61403-3 · Cited by 2,898 · cited 2× · see citing works
“CAR-T cells mediate high response rates in relapsed/refractory high-grade B cell malignancies, but less than 50% of patients experience long-term disease control and CAR-T cells have not demonstrated reproducible efficacy against solid tumors (Davila et al., 2014; Lee et al., 2015; Majzner and Mackall, 2019; Maude et…”
BackgroundSelf-citationAn improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues
Corces, M. R., Trevino, A. E., Hamilton, E. G., Greenside, P. G., Sinnott-Armstrong, N. A., Vesuna, S., Satpathy, A. T., Rubin, A. J., Montine, K. S., Wu, B., et al. (2017) · Nature Methods · doi:10.1038/nmeth.4396 · Cited by 2,496 · cited 1× · see citing works
“ATAC-seq CAR-T cells were sorted on CD8 (see Cell Sorting) and processed for ATAC-seq, which was carried out as previously reported (Corces et al., 2017).”
MethodSelf-citationEfficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
Davila, M. L., Rivière, I., Wang, X., Bartido, S. M., Park, J. H., Curran, K. J., Chung, S. S., Stefanski, J., Bórquez-Ojeda, O., Olszewska, M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008226 · Cited by 2,484 · cited 2× · see citing works
“CAR-T cells mediate high response rates in relapsed/refractory high-grade B cell malignancies, but less than 50% of patients experience long-term disease control and CAR-T cells have not demonstrated reproducible efficacy against solid tumors (Davila et al., 2014; Lee et al., 2015; Majzner and Mackall, 2019; Maude et…”
BackgroundMolecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.09.006 · Cited by 2,103 · cited 6× · see citing works
“Consistent with murine models of viral infection wherein antigen clearance induces T cell memory rather than exhaustion (Joshi et al., 2007; Rutishauser et al., 2009; Wherry et al., 2007; Wherry et al., 2004), early cessation of tonic CAR signaling (RestedD7-11) redirected T cell differentiation away from exhaustion a…”
BackgroundResultInfluentialMiller, B. C., Sen, D. R., Al Abosy, R., Bi, K., Virkud, Y. V., LaFleur, M. W., Yates, K. B., Lako, A., Felt, K., Naik, G. S., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0312-6 · Cited by 2,087 · cited 5× · see citing works
“Several groups have sought to identify subsets of exhausted T cells that retain the capacity for reversal of the exhaustion program (Im et al., 2016; Miller et al., 2019; Utzschneider et al., 2016; Utzschneider et al., 2013).”
BackgroundInfluentialDefining CD8+ T cells that provide the proliferative burst after PD-1 therapy
Im, S. J., Hashimoto, M., Gerner, M. Y., Lee, J., Kissick, H. T., Burger, M. C., Shan, Q., Hale, J. S., Lee, J., Nasti, T. H., et al. (2016) · Nature · doi:10.1038/nature19330 · Cited by 2,070 · cited 7× · see citing works
“Several groups have sought to identify subsets of exhausted T cells that retain the capacity for reversal of the exhaustion program (Im et al., 2016; Miller et al., 2019; Utzschneider et al., 2016; Utzschneider et al., 2013).”
BackgroundResultInfluentialDefining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Sade-Feldman, M., Yizhak, K., Bjorgaard, S. L., Ray, J. P., de Boer, C. G., Jenkins, R. W., Lieb, D. J., Chen, J. H., Frederick, D. T., Barzily-Rokni, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.038 · Cited by 2,053 · see citing works
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2205 · Cited by 1,978 · cited 2× · see citing works
“Chronic antigen stimulation induces T cell exhaustion, a differentiation state associated with a heritable epigenetic imprint that is distinct from that found in effector and memory T cells (Pauken et al., 2016; Philip et al., 2017; Schietinger et al., 2012; Schietinger et al., 2016; Sen et al., 2016; Wherry et al., 2…”
BackgroundJoshi, N. S., Cui, W., Chandele, A., Lee, H. K., Urso, D. R., Hagman, J., Gapin, L., & Kaech, S. M. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.010 · Cited by 1,861 · cited 4× · see citing works
“RestedD7-11 cells also exhibited a sharp decline in T-bet and Blimp-1 expression levels and co-expression frequency (Figure S2F), consistent with transcriptional reprogramming of the population (Joshi et al., 2007; Rutishauser et al., 2009).”
BackgroundResultInfluentialTargeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
Eyquem, J., Mansilla-Soto, J., Giavridis, T., van der Stegen, S. J. C., Hamieh, M., Cunanan, K. M., Odak, A., Gönen, M., & Sadelain, M. (2017) · Nature · doi:10.1038/nature21405 · Cited by 1,831 · cited 2× · see citing works
“T cell exhaustion has been implicated as an important factor limiting the efficacy of CAR-T cells against cancer (Eyquem et al., 2017; Fraietta et al., 2018a; Fraietta et al., 2018b) and can be driven by excessive CAR signaling as a result of high antigen burden or tonic signaling induced by antigen-independent cluste…”
BackgroundLong, A. H., Haso, W. M., Shern, J. F., Wanhainen, K. M., Murgai, M., Ingaramo, M., Smith, J. P., Walker, A. J., Kohler, M. E., Venkateshwara, V. R., et al. (2015) · Nature Medicine · doi:10.1038/nm.3838 · Cited by 1,815 · cited 14× · see citing works
“We previously demonstrated that some CARs, like those incorporating a GD2-specific 14g2a scFv and CD28 co-stimulatory domain, undergo antigen-independent, tonic CAR signaling due to spontaneous receptor clustering, which promotes hallmark features of exhaustion in human T cells (Long et al., 2015; Lynn et al., 2019).”
BackgroundMethodInfluentialSelf-citationFraietta, J. A., Lacey, S. F., Orlando, E. J., Pruteanu-Malinici, I., Gohil, M., Lundh, S., Boesteanu, A. C., Wang, Y., O’Connor, R. S., Hwang, W.-T., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0010-1 · Cited by 1,785 · cited 2× · see citing works
“T cell exhaustion has been implicated as an important factor limiting the efficacy of CAR-T cells against cancer (Eyquem et al., 2017; Fraietta et al., 2018a; Fraietta et al., 2018b) and can be driven by excessive CAR signaling as a result of high antigen burden or tonic signaling induced by…”
BackgroundchromVAR: inferring transcription-factor-associated accessibility from single-cell epigenomic data
Schep, A. N., Wu, B., Buenrostro, J. D., & Greenleaf, W. J. (2017) · Nature Methods · doi:10.1038/nmeth.4401 · Cited by 1,680 · cited 1× · see citing works
“ChromVAR was used to compute the relative differential accessibility of known transcription factor motifs across different samples as previously described (Rubin et al., 2019; Schep et al., 2017).”
MethodTOX transcriptionally and epigenetically programs CD8+ T cell exhaustion
Khan, O., Giles, J. R., McDonald, S., Manne, S., Ngiow, S. F., Patel, K. P., Werner, M. T., Huang, A. C., Alexander, K. A., Wu, J. E., et al. (2019) · Nature · doi:10.1038/s41586-019-1325-x · Cited by 1,646 · cited 1× · see citing works
“Recent studies have identified TOX, TOX2, and AP-1 family members as central regulators of human T cell exhaustion that promote widespread transcriptional and epigenetic dysregulation (Alfei et al., 2019; Khan et al., 2019; Scott et al., 2019; Seo et al., 2019; Wang et al., 2019; Yao et al., 2019).”
BackgroundMolecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Wherry, E. J., Ha, S., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.11.006 · Cited by 1,355 · see citing works
Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade
Pauken, K. E., Sammons, M. A., Odorizzi, P. M., Manne, S., Godec, J., Khan, O., Drake, A. M., Chen, Z., Sen, D. R., Kurachi, M., et al. (2016) · Science · doi:10.1126/science.aaf2807 · Cited by 1,348 · cited 4× · see citing works
“…exhaustion, a differentiation state associated with a heritable epigenetic imprint that is distinct from that found in effector and memory T cells (Pauken et al., 2016; Philip et al., 2017; Schietinger et al., 2012; Schietinger et al., 2016; Sen et al., 2016; Wherry et al., 2007; Zajac et al.,…”
BackgroundInfluentialThe chromatin accessibility landscape of primary human cancers
Corces, M. R., Granja, J. M., Shams, S., Louie, B. H., Seoane, J. A., Zhou, W., Silva, T. C., Groeneveld, C., Wong, C. K., Cho, S. W., et al. (2018) · Science · doi:10.1126/science.aav1898 · Cited by 1,230 · cited 1× · see citing works
“A merged peak list was created as previously described(Corces et al., 2018).”
MethodSelf-citationTOX is a critical regulator of tumour-specific T cell differentiation
Scott, A. C., Dündar, F., Zumbo, P., Chandran, S. S., Klebanoff, C. A., Shakiba, M., Trivedi, P., Menocal, L., Appleby, H., Camara, S., et al. (2019) · Nature · doi:10.1038/s41586-019-1324-y · Cited by 1,106 · cited 2× · see citing works
“Recent studies have identified TOX, TOX2, and AP-1 family members as central regulators of human T cell exhaustion that promote widespread transcriptional and epigenetic dysregulation (Alfei et al., 2019; Khan et al., 2019; Scott et al., 2019; Seo et al., 2019; Wang et al., 2019; Yao et al., 2019).”
BackgroundResultThe Principles of Engineering Immune Cells to Treat Cancer
Lim, W. A., & June, C. H. (2017) · Cell · doi:10.1016/j.cell.2017.01.016 · Cited by 1,084 · cited 1× · see citing works
“Chimeric antigen receptors (CARs) combine a tumor antigen-recognition domain with intracellular signaling domains, thereby enabling recognition and killing of tumor cells in a major histocompatibility complex (MHC)-independent manner (Lim and June, 2017; Mackall et al., 2014).”
BackgroundUtzschneider, D. T., Charmoy, M., Chennupati, V., Pousse, L., Ferreira, D., Calderon-Copete, S. P., Danilo, M., Alfei, F., Hofmann, M., Wieland, D., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.07.021 · Cited by 1,026 · cited 7× · see citing works
“Several groups have sought to identify subsets of exhausted T cells that retain the capacity for reversal of the exhaustion program (Im et al., 2016; Miller et al., 2019; Utzschneider et al., 2016; Utzschneider et al., 2013).”
BackgroundResultInfluentialThe epigenetic landscape of T cell exhaustion
Sen, D. R., Kaminski, J., Barnitz, R. A., Kurachi, M., Gerdemann, U., Yates, K. B., Tsao, H.-W., Godec, J., LaFleur, M. W., Brown, F. D., et al. (2016) · Science · doi:10.1126/science.aae0491 · Cited by 986 · cited 2× · see citing works
“Chronic antigen stimulation induces T cell exhaustion, a differentiation state associated with a heritable epigenetic imprint that is distinct from that found in effector and memory T cells (Pauken et al., 2016; Philip et al., 2017; Schietinger et al., 2012; Schietinger et al., 2016; Sen et al., 2016; Wherry et al., 2…”
BackgroundChromatin states define tumour-specific T cell dysfunction and reprogramming
Philip, M., Fairchild, L., Sun, L., Horste, E. L., Camara, S., Shakiba, M., Scott, A. C., Viale, A., Lauer, P., Merghoub, T., et al. (2017) · Nature · doi:10.1038/nature22367 · Cited by 933 · cited 4× · see citing works
“Similarly, murine tumor models have revealed that exhaustion reprogrammability is associated with increased accessibility at the Tcf7 locus (Philip et al., 2017).”
BackgroundInfluentialBanaszynski, L. A., Chen, L.-C., Maynard-Smith, L. A., Ooi, A. G. L., & Wandless, T. J. (2006) · Cell · doi:10.1016/j.cell.2006.07.025 · Cited by 902 · cited 3× · see citing works
“Using a drug-regulatable platform (Banaszynski et al., 2006; Banaszynski et al., 2008) wherein a tonically signaling CAR was modified with a C-terminal destabilizing domain (DD) to enable drug-dependent control of CAR protein levels, we observed that transient inhibition of CAR surface expression,…”
BackgroundSelf-citationTOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection
Alfei, F., Kanev, K., Hofmann, M., Wu, M., Ghoneim, H. E., Roelli, P., Utzschneider, D. T., von Hoesslin, M., Cullen, J. G., Fan, Y., et al. (2019) · Nature · doi:10.1038/s41586-019-1326-9 · Cited by 900 · cited 1× · see citing works
“Recent studies have identified TOX, TOX2, and AP-1 family members as central regulators of human T cell exhaustion that promote widespread transcriptional and epigenetic dysregulation (Alfei et al., 2019; Khan et al., 2019; Scott et al., 2019; Seo et al., 2019; Wang et al., 2019; Yao et al., 2019).”
Backgroundc-Jun overexpression in CAR T cells induces exhaustion resistance
Lynn, R. C., Weber, E. W., Sotillo, E., Gennert, D., Xu, P., Good, Z., Anbunathan, H., Lattin, J., Jones, R., Tieu, V., et al. (2019) · Nature · doi:10.1038/s41586-019-1805-z · Cited by 891 · cited 7× · see citing works
“…modified a validated in vitro model of CAR-associated T cell exhaustion, wherein tonic CAR signaling induces hallmark phenotypic, functional, transcriptomic and epigenetic features of exhaustion within 11 days (HA.28ζ) (Lynn et al., 2019), to enable precise, drug-dependent control of CAR signaling.”
BackgroundMethodInfluentialSelf-citationNR4A transcription factors limit CAR T cell function in solid tumours
Chen, J., López-Moyado, I. F., Seo, H., Lio, C.-W. J., Hempleman, L. J., Sekiya, T., Yoshimura, A., Scott-Browne, J. P., & Rao, A. (2019) · Nature · doi:10.1038/s41586-019-0985-x · Cited by 874 · cited 5× · see citing works
“…which is associated with a progenitor exhausted cell population that retains anti-tumor functionality and is responsive to checkpoint blockade (Chen et al., 2019c; Im et al., 2016; Jadhav et al., 2019; Utzschneider et al., 2016), was similar in both Always ON and RestedD7-11 conditions and…”
BackgroundInfluentialDisruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells
Fraietta, J. A., Nobles, C. L., Sammons, M. A., Lundh, S., Carty, S. A., Reich, T. J., Cogdill, A. P., Morrissette, J. J. D., DeNizio, J. E., Reddy, S., et al. (2018) · Nature · doi:10.1038/s41586-018-0178-z · Cited by 862 · cited 2× · see citing works
“T cell exhaustion has been implicated as an important factor limiting the efficacy of CAR-T cells against cancer (Eyquem et al., 2017; Fraietta et al., 2018a; Fraietta et al., 2018b) and can be driven by excessive CAR signaling as a result of high antigen burden or tonic signaling induced by…”
BackgroundThe Transcription Factor NFAT Promotes Exhaustion of Activated CD8 + T Cells
Martinez, G. J., Pereira, R. M., Äijö, T., Kim, E. Y., Marangoni, F., Pipkin, M. E., Togher, S., Heissmeyer, V., Zhang, Y. C., Crotty, S., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.01.006 · Cited by 857 · cited 2× · see citing works
“12 AP-1 family TF motifs (BATF, BATF3, JUNB, NFATC2), which are known to promote T cell exhaustion (Kurachi et al., 2014; Lynn et al., 2019; Man et al., 2017; Martinez et al., 2015; Scott-Browne et al., 2016), were highly enriched in accessible regions of the Always ON epigenome, but rendered less accessible following…”
BackgroundSeo, H., Chen, J., González-Avalos, E., Samaniego-Castruita, D., Das, A., Wang, Y. H., López-Moyado, I. F., Georges, R. O., Zhang, W., Onodera, A., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1905675116 · Cited by 808 · cited 3× · see citing works
“Recent studies have identified TOX, TOX2, and AP-1 family members as central regulators of human T cell exhaustion that promote widespread transcriptional and epigenetic dysregulation (Alfei et al., 2019; Khan et al., 2019; Scott et al., 2019; Seo et al., 2019; Wang et al., 2019; Yao et al., 2019).”
BackgroundNormalization of mass cytometry data with bead standards
Finck, R., Simonds, E. F., Jager, A., Krishnaswamy, S., Sachs, K., Fantl, W. J., Pe’er, D., Nolan, G. P., & Bendall, S. C. (2013) · Cytometry Part A · doi:10.1002/cyto.a.22271 · Cited by 737 · cited 2× · see citing works
“QUANTIFICATION AND STATISTICAL ANALYSES Mass cytometry data processing and analysis Acquired data was normalized and debarcoded using MATLAB-based software (Finck et al., 2013; Zunder et al., 2015).”
MethodSchietinger, A., Philip, M., Krisnawan, V. E., Chiu, E. Y., Delrow, J. J., Basom, R. S., Lauer, P., Brockstedt, D. G., Knoblaugh, S. E., Hämmerling, G. J., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.07.011 · Cited by 720 · cited 2× · see citing works
“Chronic antigen stimulation induces T cell exhaustion, a differentiation state associated with a heritable epigenetic imprint that is distinct from that found in effector and memory T cells (Pauken et al., 2016; Philip et al., 2017; Schietinger et al., 2012; Schietinger et al., 2016; Sen et al., 2016; Wherry et al., 2…”
BackgroundTCF-1-centered transcriptional network drives an effector versus exhausted CD8 T cell-fate decision
Chen, Z., Ji, Z., Ngiow, S. F., Manne, S., Cai, Z., Huang, A. C., Johnson, J., Staupe, R. P., Bengsch, B., Xu, C., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.09.013 · Cited by 709 · cited 5× · see citing works
“…which is associated with a progenitor exhausted cell population that retains anti-tumor functionality and is responsive to checkpoint blockade (Chen et al., 2019c; Im et al., 2016; Jadhav et al., 2019; Utzschneider et al., 2016), was similar in both Always ON and RestedD7-11 conditions and…”
BackgroundInfluentialRemote control of therapeutic T cells through a small molecule–gated chimeric receptor
Wu, C.-Y., Roybal, K. T., Puchner, E. M., Onuffer, J., & Lim, W. A. (2015) · Science · doi:10.1126/science.aab4077 · Cited by 692 · cited 1× · see citing works
“Advances in synthetic biology have enabled the development of several tunable CAR platforms which have been optimized to mitigate CAR-mediated toxicity (Bejestani et al., 2017; Cho et al., 2018; Leung et al., 2019; Rodgers et al., 2016; Wu et al., 2015).”
BackgroundUniversal Chimeric Antigen Receptors for Multiplexed and Logical Control of T Cell Responses
Cho, J. H., Collins, J. J., & Wong, W. W. (2018) · Cell · doi:10.1016/j.cell.2018.03.038 · Cited by 685 · cited 1× · see citing works
“Advances in synthetic biology have enabled the development of several tunable CAR platforms which have been optimized to mitigate CAR-mediated toxicity (Bejestani et al., 2017; Cho et al., 2018; Leung et al., 2019; Rodgers et al., 2016; Wu et al., 2015).”
BackgroundRunx3 programs CD8+ T cell residency in non-lymphoid tissues and tumours
Milner, J. J., Toma, C., Yu, B., Zhang, K., Omilusik, K., Phan, A. T., Wang, D., Getzler, A. J., Nguyen, T., Crotty, S., et al. (2017) · Nature · doi:10.1038/nature24993 · Cited by 677 · cited 2× · see citing works
“TF binding motifs for genes that have been implicated in T cell memory were exclusively accessible in rested conditions (TCF7/TCF7L2, LEF1, RUNX family, FOXO family) (Hu and Chen, 2013; Jadhav et al., 2019; Kratchmarov et al., 2018; Michelini et al., 2013; Milner et al., 2017; Rao et al., 2012; Sullivan et al., 2012;…”
BackgroundResultClinical lessons learned from the first leg of the CAR T cell journey
Majzner, R. G., & Mackall, C. L. (2019) · Nature Medicine · doi:10.1038/s41591-019-0564-6 · Cited by 636 · see citing works
Self-citationLatchman, Y. E., Liang, S. C., Wu, Y., Chernova, T., Sobel, R. A., Klemm, M., Kuchroo, V. K., Freeman, G. J., & Sharpe, A. H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307252101 · Cited by 631 · cited 2× · see citing works
“Since PD-1 and PD-L1 are both expressed on activated T cells (Latchman et al., 2004) (Figure S2E), in some experiments we included a condition wherein Always ON T cells were cultured with aPD-1-blocking antibody from D7-15 to compare the degree of reprogramming induced by checkpoint blockade with that of transient res…”
ResultRutishauser, R. L., Martins, G. A., Kalachikov, S. M., Chandele, A., Parish, I. A., Meffre, E., Jacob, J., Calame, K. L., & Kaech, S. M. (2009) · Immunity · doi:10.1016/j.immuni.2009.05.014 · Cited by 612 · cited 4× · see citing works
“RestedD7-11 cells also exhibited a sharp decline in T-bet and Blimp-1 expression levels and co-expression frequency (Figure S2F), consistent with transcriptional reprogramming of the population (Joshi et al., 2007; Rutishauser et al., 2009).”
BackgroundResultInfluentialZunder, E. R., Finck, R., Behbehani, G. K., Amir, E.-A. D., Krishnaswamy, S., Gonzalez, V. D., Lorang, C. G., Bjornson, Z., Spitzer, M. H., Bodenmiller, B., et al. (2015) · Nature Protocols · doi:10.1038/nprot.2015.020 · Cited by 596 · cited 2× · see citing works
“QUANTIFICATION AND STATISTICAL ANALYSES Mass cytometry data processing and analysis Acquired data was normalized and debarcoded using MATLAB-based software (Finck et al., 2013; Zunder et al., 2015).”
MethodSingle-cell RNA-seq reveals TOX as a key regulator of CD8+ T cell persistence in chronic infection
Yao, C., Sun, H.-W., Lacey, N. E., Ji, Y., Moseman, E. A., Shih, H.-Y., Heuston, E. F., Kirby, M., Anderson, S., Cheng, J., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0403-4 · Cited by 549 · cited 1× · see citing works
“Recent studies have identified TOX, TOX2, and AP-1 family members as central regulators of human T cell exhaustion that promote widespread transcriptional and epigenetic dysregulation (Alfei et al., 2019; Khan et al., 2019; Scott et al., 2019; Seo et al., 2019; Wang et al., 2019; Yao et al., 2019).”
BackgroundThe tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells
Mestermann, K., Giavridis, T., Weber, J., Rydzek, J., Frenz, S., Nerreter, T., Mades, A., Sadelain, M., Einsele, H., & Hudecek, M. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau5907 · Cited by 531 · cited 8× · see citing works
“Reinvigoration of exhausted CAR-T cells using the Src kinase inhibitor dasatinib We and others recently demonstrated that dasatinib, an FDA-approved tyrosine kinase inhibitor, suppresses CAR-T cell activation via rapid and reversible antagonism of proximal T cell receptor (TCR) signaling kinases (Mestermann et al., 20…”
BackgroundMethodInfluentialAntigen-independent memory CD8 T cells do not develop during chronic viral infection
Wherry, E. J., Barber, D. L., Kaech, S. M., Blattman, J. N., & Ahmed, R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407192101 · Cited by 495 · cited 5× · see citing works
“Consistent with murine models of viral infection wherein antigen clearance induces T cell memory rather than exhaustion (Joshi et al., 2007; Rutishauser et al., 2009; Wherry et al., 2007; Wherry et al., 2004), early cessation of tonic CAR signaling (RestedD7-11) redirected T cell differentiation away from exhaustion a…”
BackgroundResultInfluentialMan, K., Gabriel, S. S., Liao, Y., Gloury, R., Preston, S., Henstridge, D. C., Pellegrini, M., Zehn, D., Berberich‐Siebelt, F., Febbraio, M. A., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.11.021 · Cited by 489 · cited 2× · see citing works
“AP-1 family TF motifs (BATF, BATF3, JUNB, NFATC2), which are known to promote T cell exhaustion (Kurachi et al., 2014; Lynn et al., 2019; Man et al., 2017; Martinez et al., 2015; Scott-Browne et al., 2016), were highly enriched in accessible regions of the Always ON epigenome, but rendered less…”
BackgroundAutomated mapping of phenotype space with single-cell data
Samusik, N., Good, Z., Spitzer, M. H., Davis, K. L., & Nolan, G. P. (2016) · Nature Methods · doi:10.1038/nmeth.3863 · Cited by 419 · see citing works
Self-citationSwitch-mediated activation and retargeting of CAR-T cells for B-cell malignancies
Rodgers, D. T., Mazagova, M., Hampton, E. N., Cao, Y. J., Ramadoss, N. S., Hardy, I. R., Schulman, A. D., Du, J., Wang, F., Singer, O., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1524155113 · Cited by 398 · cited 1× · see citing works
“Advances in synthetic biology have enabled the development of several tunable CAR platforms which have been optimized to mitigate CAR-mediated toxicity (Bejestani et al., 2017; Cho et al., 2018; Leung et al., 2019; Rodgers et al., 2016; Wu et al., 2015).”
BackgroundA General Chemical Method to Regulate Protein Stability in the Mammalian Central Nervous System
Iwamoto, M., Björklund, T., Lundberg, C., Kirik, D., & Wandless, T. J. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.07.009 · Cited by 391 · cited 2× · see citing works
“To interrogate DD-CAR functionality in vivo, we substituted the FKBP DD for an E. coli-derived dihydrofolate reductase DD (ecDHFR) (Iwamoto et al., 2010).”
MethodSelf-citationKurachi, M., Barnitz, R. A., Yosef, N., Odorizzi, P. M., DiIorio, M. A., Lemieux, M. E., Yates, K. B., Godec, J., Klatt, M. G., Regev, A., et al. (2014) · Nature Immunology · doi:10.1038/ni.2834 · Cited by 384 · cited 2× · see citing works
“AP-1 family TF motifs (BATF, BATF3, JUNB, NFATC2), which are known to promote T cell exhaustion (Kurachi et al., 2014; Lynn et al., 2019; Man et al., 2017; Martinez et al., 2015; Scott-Browne et al., 2016), were highly enriched in accessible regions of the Always ON epigenome, but rendered less…”
BackgroundThe polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion
Kamminga, L. M., Bystrykh, L. V., de Boer, A., Houwer, S., Douma, J., Weersing, E., Dontje, B., & de Haan, G. (2006) · Blood · doi:10.1182/blood-2005-09-3585 · Cited by 376 · cited 2× · see citing works
“Recent studies suggest that the epigenetic modifier, enhancer of zeste homolog 2 (EZH2), which catalyzes trimethylation on histone 3 at lysine 27 (H3K27me3) as a subunit of the polycomb repressive complex 2 (PRC2), prevents hematopoietic stem cell exhaustion and is critical for T cell differentiation, maintenance of T…”
BackgroundDefining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Sade-Feldman, M., Yizhak, K., Bjorgaard, S. L., Ray, J. P., de Boer, C. G., Jenkins, R. W., Lieb, D. J., Chen, J. H., Frederick, D. T., Barzily-Rokni, M., et al. (2019) · Cell · doi:10.1016/j.cell.2018.12.034 · Cited by 344 · see citing works
Antigen receptor repertoire profiling from RNA-seq data
Bolotin, D. A., Poslavskii, S., Davydov, A. N., Frenkel, F. E., Fanchi, L. F., Zolotareva, O. I., Hemmers, S., Putintseva, E. V., Obraztsova, A., Shugay, M., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3979 · Cited by 318 · see citing works
Rubin, A. J., Parker, K. R., Satpathy, A. T., Qi, Y., Wu, B., Ong, A. J., Mumbach, M. R., Ji, A. L., Kim, D. S., Cho, S. W., et al. (2019) · Cell · doi:10.1016/j.cell.2018.11.022 · Cited by 314 · see citing works
Self-citationDynamic Changes in Chromatin Accessibility Occur in CD8 + T Cells Responding to Viral Infection
Scott-Browne, J. P., López-Moyado, I. F., Trifari, S., Wong, V., Chávez, L., Rao, A., & Pereira, R. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.10.028 · Cited by 309 · cited 1× · see citing works
“…JUNB, NFATC2), which are known to promote T cell exhaustion (Kurachi et al., 2014; Lynn et al., 2019; Man et al., 2017; Martinez et al., 2015; Scott-Browne et al., 2016), were highly enriched in accessible regions of the Always ON epigenome, but rendered less accessible following rest…”
BackgroundSchade, A. E., Schieven, G. L., Townsend, R. C., Jankowska, A. M., Susulic, V., Zhang, R., Szpurka, H., & Maciejewski, J. P. (2007) · Blood · doi:10.1182/blood-2007-04-084814 · Cited by 296 · cited 1× · see citing works
“We observed similar phenotypic and functional reinvigoration following transient exposure to dasatinib, a Src kinase inhibitor that potently and reversibly inhibits TCR and CAR signaling (Lee et al., 2010; Mestermann et al., 2019; Schade et al., 2007; Weber et al., 2019).”
BackgroundInfluentialRao, R. R., Li, Q., Bupp, M. G., & Shrikant, P. A. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.015 · Cited by 293 · cited 2× · see citing works
“TF binding motifs for genes that have been implicated in T cell memory were exclusively accessible in rested conditions (TCF7/TCF7L2, LEF1, RUNX family, FOXO family) (Hu and Chen, 2013; Jadhav et al., 2019; Kratchmarov et al., 2018; Michelini et al., 2013; Milner et al., 2017; Rao et al., 2012; Sullivan et al., 2012;…”
BackgroundResultWang, X., He, Q., Shen, H., Xia, A., Tian, W., Yu, W., & Sun, B. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.05.015 · Cited by 287 · cited 1× · see citing works
“Recent studies have identified TOX, TOX2, and AP-1 family members as central regulators of human T cell exhaustion that promote widespread transcriptional and epigenetic dysregulation (Alfei et al., 2019; Khan et al., 2019; Scott et al., 2019; Seo et al., 2019; Wang et al., 2019; Yao et al., 2019).”
BackgroundT cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion
Utzschneider, D. T., Legat, A., Marraco, S. A. F., Carrié, L., Luescher, I. F., Speiser, D. E., & Zehn, D. (2013) · Nature Immunology · doi:10.1038/ni.2606 · Cited by 282 · cited 1× · see citing works
“Several groups have sought to identify subsets of exhausted T cells that retain the capacity for reversal of the exhaustion program (Im et al., 2016; Miller et al., 2019; Utzschneider et al., 2016; Utzschneider et al., 2013).”
BackgroundPharmacologic control of CAR-T cell function using dasatinib
Weber, E. W., Lynn, R. C., Sotillo, E., Lattin, J., Xu, P., & Mackall, C. L. (2019) · Blood Advances · doi:10.1182/bloodadvances.2018028720 · Cited by 240 · cited 7× · see citing works
“Reinvigoration of exhausted CAR-T cells using the Src kinase inhibitor dasatinib We and others recently demonstrated that dasatinib, an FDA-approved tyrosine kinase inhibitor, suppresses CAR-T cell activation via rapid and reversible antagonism of proximal T cell receptor (TCR) signaling kinases (Mestermann et al., 20…”
BackgroundMethodInfluentialSelf-citationDifferentiation of CD8 memory T cells depends on Foxo1
Michelini, R. H., Doedens, A. L., Goldrath, A. W., & Hedrick, S. Μ. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20130392 · Cited by 228 · cited 2× · see citing works
“TF binding motifs for genes that have been implicated in T cell memory were exclusively accessible in rested conditions (TCF7/TCF7L2, LEF1, RUNX family, FOXO family) (Hu and Chen, 2013; Jadhav et al., 2019; Kratchmarov et al., 2018; Michelini et al., 2013; Milner et al., 2017; Rao et al., 2012; Sullivan et al., 2012;…”
BackgroundResultTcf1 and Lef1 transcription factors establish CD8+ T cell identity through intrinsic HDAC activity
Xing, S., Li, F., Zeng, Z., Zhao, Y., Yu, S., Shan, Q., Li, Y., Phillips, F. C., Maina, P. K., Qi, H. H., et al. (2016) · Nature Immunology · doi:10.1038/ni.3456 · Cited by 226 · cited 2× · see citing works
“TF binding motifs for genes that have been implicated in T cell memory were exclusively accessible in rested conditions (TCF7/TCF7L2, LEF1, RUNX family, FOXO family) (Hu and Chen, 2013; Jadhav et al., 2019; Kratchmarov et al., 2018; Michelini et al., 2013; Milner et al., 2017; Rao et al., 2012; Sullivan et al., 2012;…”
BackgroundResulttcR: an R package for T cell receptor repertoire advanced data analysis
Nazarov, V. I., Pogorelyy, M. V., Komech, E. A., Zvyagin, I. V., Bolotin, D. A., Shugay, M., Chudakov, D. M., Lebedev, Y. B., & Mamedov, I. Z. (2015) · BMC Bioinformatics · doi:10.1186/s12859-015-0613-1 · Cited by 223 · cited 1× · see citing works
“Clonotypes were further assessed using tcR, which enabled computation of clontype abundance and diversity estimations based on the CDR3 amino acid length and V gene usage (Nazarov et al., 2015).”
MethodRestoration of HCV-specific CD8+ T cell function by interferon-free therapy
Martin, B., Hennecke, N., Lohmann, V., Kayser, A., Neumann‐Haefelin, C., Kukolj, G., Böcher, W., & Thimme, R. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.05.043 · Cited by 223 · cited 1× · see citing works
“Indeed, improved antigen-specific T cell function has been associated with antigen clearance in humans with hepatitis C infection treated with direct acting anti-viral therapies (Burchill et al., 2015; Kohli et al., 2015; Martin et al., 2014; Shrivastava et al., 2017; Wieland et al., 2017).”
BackgroundWieland, D., Kemming, J. S., Schuch, A., Emmerich, F., Knolle, P. A., Neumann‐Haefelin, C., Held, W., Zehn, D., Hofmann, M., & Thimme, R. (2017) · Nature Communications · doi:10.1038/ncomms15050 · Cited by 214 · cited 1× · see citing works
“Indeed, improved antigen-specific T cell function has been associated with antigen clearance in humans with hepatitis C infection treated with direct acting anti-viral therapies (Burchill et al., 2015; Kohli et al., 2015; Martin et al., 2014; Shrivastava et al., 2017; Wieland et al., 2017).”
BackgroundJadhav, R., Im, S., Hu, B., Hashimoto, M., Li, P., Lin, J., Leonard, W., Greenleaf, W., Ahmed, R., & Goronzy, J. (2019) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1903520116 · Cited by 203 · cited 8× · see citing works
“…exhausted cell population that retains anti-tumor functionality and is responsive to checkpoint blockade (Chen et al., 2019c; Im et al., 2016; Jadhav et al., 2019; Utzschneider et al., 2016), was similar in both Always ON and RestedD7-11 conditions and represented approximately 10% of total…”
BackgroundResultInfluentialWang, D., Diao, H., Getzler, A. J., Rogal, W., Frederick, M. A., Milner, J., Yu, B., Crotty, S., Goldrath, A. W., & Pipkin, M. E. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.028 · Cited by 201 · see citing works
Rescued Tolerant CD8 T Cells Are Preprogrammed to Reestablish the Tolerant State
Schietinger, A., Delrow, J. J., Basom, R., Blattman, J. N., & Greenberg, P. D. (2012) · Science · doi:10.1126/science.1214277 · Cited by 172 · cited 1× · see citing works
“…a differentiation state associated with a heritable epigenetic imprint that is distinct from that found in effector and memory T cells (Pauken et al., 2016; Philip et al., 2017; Schietinger et al., 2012; Schietinger et al., 2016; Sen et al., 2016; Wherry et al., 2007; Zajac et al., 1998).”
BackgroundKohli, A., Osinusi, A., Sims, Z., Nelson, A. K., Meissner, E. G., Barrett, L. L., Bon, D., Marti, M., Silk, R., Kotb, C., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61228-9 · Cited by 149 · cited 1× · see citing works
“Indeed, improved antigen-specific T cell function has been associated with antigen clearance in humans with hepatitis C infection treated with direct acting anti-viral therapies (Burchill et al., 2015; Kohli et al., 2015; Martin et al., 2014; Shrivastava et al., 2017; Wieland et al., 2017).”
BackgroundChemical control of protein stability and function in living mice
Banaszynski, L. A., Sellmyer, M. A., Contag, C. H., Wandless, T. J., & Thorne, S. H. (2008) · Nature Medicine · doi:10.1038/nm.1754 · Cited by 147 · cited 2× · see citing works
“Using a drug-regulatable platform (Banaszynski et al., 2006; Banaszynski et al., 2008) wherein a tonically signaling CAR was modified with a C-terminal destabilizing domain (DD) to enable drug-dependent control of CAR protein levels, we observed that transient inhibition of CAR surface expression,…”
BackgroundSelf-citationHu, G., & Chen, J. (2013) · Nature Communications · doi:10.1038/ncomms3830 · Cited by 132 · cited 2× · see citing works
“TF binding motifs for genes that have been implicated in T cell memory were exclusively accessible in rested conditions (TCF7/TCF7L2, LEF1, RUNX family, FOXO family) (Hu and Chen, 2013; Jadhav et al., 2019; Kratchmarov et al., 2018; Michelini et al., 2013; Milner et al., 2017; Rao et al., 2012; Sullivan et al., 2012;…”
BackgroundResultHe, S., Liu, Y., Meng, L., Sun, H., Wang, Y., Ji, Y., Purushe, J., Chen, P., Li, C., Madžo, J., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02187-8 · Cited by 129 · see citing works
TCF1 expression marks self-renewing human CD8+ T cells
Kratchmarov, R., Magun, A. M., & Reiner, S. L. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018016279 · Cited by 116 · cited 2× · see citing works
“TF binding motifs for genes that have been implicated in T cell memory were exclusively accessible in rested conditions (TCF7/TCF7L2, LEF1, RUNX family, FOXO family) (Hu and Chen, 2013; Jadhav et al., 2019; Kratchmarov et al., 2018; Michelini et al., 2013; Milner et al., 2017; Rao et al., 2012; Sullivan et al., 2012;…”
BackgroundResultBurchill, M. A., Golden‐Mason, L., Wind‐Rotolo, M., & Rosen, H. R. (2015) · Journal of Viral Hepatitis · doi:10.1111/jvh.12465 · Cited by 105 · see citing works
Switchable control over in vivo CAR T expansion, B cell depletion, and induction of memory
Viaud, S., Ma, J. S. Y., Hardy, I. R., Hampton, E. N., Benish, B., Sherwood, L., Núñez, V., Ackerman, C. J., Khialeeva, E., Weglarz, M., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1810060115 · Cited by 96 · see citing works
FOXO3 Regulates CD8 T Cell Memory by T Cell-Intrinsic Mechanisms
Sullivan, J. A., Kim, E. H., Plisch, E. H., Peng, S. L., & Suresh, M. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002533 · Cited by 91 · cited 2× · see citing works
“TF binding motifs for genes that have been implicated in T cell memory were exclusively accessible in rested conditions (TCF7/TCF7L2, LEF1, RUNX family, FOXO family) (Hu and Chen, 2013; Jadhav et al., 2019; Kratchmarov et al., 2018; Michelini et al., 2013; Milner et al., 2017; Rao et al., 2012; Sullivan et al., 2012;…”
BackgroundResultLck is a key target of imatinib and dasatinib in T-cell activation
Lee, K. C., Ouwehand, I., Giannini, A. L. M., Thomas, N. S. B., Dibb, N. J., & Bijlmakers, M.-J. (2010) · Leukemia · doi:10.1038/leu.2010.11 · Cited by 91 · cited 1× · see citing works
“We observed similar phenotypic and functional reinvigoration following transient exposure to dasatinib, a Src kinase inhibitor that potently and reversibly inhibits TCR and CAR signaling (Lee et al., 2010; Mestermann et al., 2019; Schade et al., 2007; Weber et al., 2019).”
BackgroundInfluentialImmune-based therapies for childhood cancer
Mackall, C. L., Merchant, M. S., & Fry, T. J. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.177 · Cited by 91 · cited 1× · see citing works
“Chimeric antigen receptors (CARs) combine a tumor antigen-recognition domain with intracellular signaling domains, thereby enabling recognition and killing of tumor cells in a major histocompatibility complex (MHC)-independent manner (Lim and June, 2017; Mackall et al., 2014).”
BackgroundSelf-citationLeung, W., Gay, J. W., Martin, U., Garrett, T. E., Horton, H. M., Certo, M. T., Blazar, B. R., Morgan, R. A., Gregory, P. D., Jarjour, J., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.124430 · Cited by 79 · cited 1× · see citing works
“Advances in synthetic biology have enabled the development of several tunable CAR platforms which have been optimized to mitigate CAR-mediated toxicity (Bejestani et al., 2017; Cho et al., 2018; Leung et al., 2019; Rodgers et al., 2016; Wu et al., 2015).”
BackgroundGood, Z., Borges, L., Gonzalez, N. V., Sahaf, B., Samusik, N., Tibshirani, R. J., Nolan, G. P., & Bendall, S. C. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0033-2 · Cited by 58 · cited 2× · see citing works
“**, p<0.01; ****, p<0.0001; ns, p>0.05 Unbiased multidimensional analyses using force-directed layouts (FDLs) (Good et al., 2019; Samusik et al., 2016), which map phenotypically similar cells closely together and dissimilar cells farther apart, illustrated phenotypic trajectories towards exhaustion…”
BackgroundInfluentialSelf-citationChen, X., Cao, G., Wu, J. S., Wang, X., Pan, Z., Gao, J., Qin, T., Xu, L., Li, Z., Hao, Y., et al. (2019) · Cellular and Molecular Immunology · doi:10.1038/s41423-019-0219-z · Cited by 52 · cited 5× · see citing works
“…which is associated with a progenitor exhausted cell population that retains anti-tumor functionality and is responsive to checkpoint blockade (Chen et al., 2019c; Im et al., 2016; Jadhav et al., 2019; Utzschneider et al., 2016), was similar in both Always ON and RestedD7-11 conditions and…”
BackgroundInfluentialHekim, C., Ilander, M. M., Yan, J., Michaud, E., Smykla, R. A., Vähä-Koskela, M. J. V., Savola, P., Tähtinen, S., Saikko, L., Hemminki, A., et al. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0061-t · Cited by 50 · cited 1× · see citing works
“Similarly, an immunomodulatory effect of dasatinib on T cells has been associated with improved anti-tumor immunity (Hekim et al., 2017).”
BackgroundBejestani, E. P., Cartellieri, M., Bergmann, R., Ehninger, A., Loff, S., Krämer, M., Spehr, J., Dietrich, A., Feldmann, A., Albert, S., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1342909 · Cited by 37 · see citing works
Augmentation of hepatitis C virus‐specific immunity and sustained virologic response
Shrivastava, S., Wilson, E. M. P., Poonia, B., Tang, L., Osinusi, A. O., Kohli, A., & Kottilil, S. (2017) · Journal of Viral Hepatitis · doi:10.1111/jvh.12702 · Cited by 30 · see citing works
c-Jun Overexpressing CAR-T Cells are Exhaustion-Resistant and Mediate Enhanced Antitumor ActivityPreprint
Lynn, R. C., Weber, E. W., Gennert, D. G., Sotillo, E., Xu, P., Good, Z., Anbunathan, H., Jones, R. C., Tieu, V., Granja, J. M., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/653725 · Cited by 8 · cited 16× · see citing works
“We previously demonstrated that some CARs, like those incorporating a GD2-specific 14g2a scFv and CD28 co-stimulatory domain, undergo antigen-independent, tonic CAR signaling due to spontaneous receptor clustering, which promotes hallmark features of exhaustion in human T cells (Long et al., 2015; Lynn et al., 2019).”
BackgroundMethodInfluentialSelf-citationAbstract 937: Nr4a transcription factors limit CAR T-cell function in solid tumors
Chen, J., López-Moyado, I. F., Seo, H., Lio, C. J., Hempleman, L. J., Sekiya, T., Yoshimura, A., Scott-Browne, J. P., & Rao, A. (2019) · Immunology · doi:10.1158/1538-7445.sabcs18-937 · Cited by 3 · see citing works
Abstract 937: Nr4a transcription factors limit CAR T-cell function in solid tumors
Chen, J., López-Moyado, I. F., Seo, H., Lio, C. J., Hempleman, L. J., Sekiya, T., Yoshimura, A., Scott-Browne, J. P., & Rao, A. (2019) · Cancer Research · doi:10.1158/1538-7445.am2019-937 · Cited by 2 · cited 5× · see citing works
“…which is associated with a progenitor exhausted cell population that retains anti-tumor functionality and is responsive to checkpoint blockade (Chen et al., 2019c; Im et al., 2016; Jadhav et al., 2019; Utzschneider et al., 2016), was similar in both Always ON and RestedD7-11 conditions and…”
BackgroundInfluential
Flagged first, then by citations
Cited by
Sorted by citations
Engineering CAR-T Cells for Next-Generation Cancer Therapy
Hong, M., Clubb, J. D., & Chen, Y. Y. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.07.005 · Cited by 644 · see citing works
Navigating CAR-T cells through the solid-tumour microenvironment
Hou, A. J., Chen, L. C., & Chen, Y. Y. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00189-2 · Cited by 556 · see citing works
Self-citationThe Emerging Landscape of Immune Cell Therapies
Weber, E. W., Maus, M. V., & Mackall, C. L. (2020) · Cell · doi:10.1016/j.cell.2020.03.001 · Cited by 445 · see citing works
“Finally, transient disruption of tonic CAR signaling via regulation of CAR protein can epigenetically repro- 54 Cell 181, April 2, 2020 gram exhausted CAR T cells and augment efficacy in pre-clinical models (Weber et al., 2020).”
BackgroundSelf-citationReversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide
Jan, M., Scarfò, I., Larson, R. C., Walker, A., Schmidts, A., Guirguis, A. A., Gasser, J. A., Slabicki, M. M., Bouffard, A. A., Castaño, A. P., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abb6295 · Cited by 270 · see citing works
“Using dasatinib or a destabilization domain, transient rest from CAR signaling protects against T cell exhaustion ( 50 ); future work may establish whether lenalidomide ON-or OFF-switch control enhances the phenotype and function of exhaustion-prone CARs.”
Enhanced safety and efficacy of protease-regulated CAR-T cell receptors
Labanieh, L., Majzner, R. G., Klysz, D. D., Sotillo, E., Fisher, C., Vilches-Moure, J. G., Pacheco, K. Z., Malipatlolla, M. B., Xu, P., Hui, J. H., et al. (2022) · Cell · doi:10.1016/j.cell.2022.03.041 · Cited by 227 · see citing works
“These results provide clear evidence that SNIP CARs are biologically distinct and more potent than constitutive CARs, which we posit results from variability in GPV levels associated with normal PK that oscillate CAR signaling, thereby preventing exhaustion and improving CAR-T cell function (Weber et al., 2020).”
BackgroundSelf-citationChimeric STAR receptors using TCR machinery mediate robust responses against solid tumors
Liu, Y., Liu, G., Wang, J., Zheng, Z., Jia, L., Rui, W., Huang, D., Zhou, Z., Zhou, L., Wu, X., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abb5191 · Cited by 168 · see citing works
Cancer therapies based on targeted protein degradation — lessons learned with lenalidomide
Jan, M., Sperling, A. S., & Ebert, B. L. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00479-z · Cited by 137 · see citing works
Determinants of Response and Mechanisms of Resistance of CAR T-cell Therapy in Multiple Myeloma
van de Donk, N. W. C. J., Themeli, M., & Usmani, S. Z. (2021) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-20-0227 · Cited by 88 · see citing works
Dynamic chromatin regulatory landscape of human CAR T cell exhaustion
Gennert, D. G., Lynn, R. C., Granja, J. M., Weber, E. W., Mumbach, M. R., Zhao, Y., Duren, Z., Sotillo, E., Greenleaf, W. J., Wong, W. H., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2104758118 · Cited by 70 · see citing works
“…reported that human HA-28z CAR T cells, targeting the GD2 surface marker, exhibit tonic signaling and lead to an exhausted T cell phenotype following 10 days of transduction, in contrast to the non-exhausted phenotype of human CD19-28z CAR T cells, targeting the CD19 surface marker 7,16 .”
BackgroundSelf-citationAll systems go: converging synthetic biology and combinatorial treatment for CAR-T cell therapy
Lanitis, E., Coukos, G., & Irving, M. B. (2020) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2020.01.009 · Cited by 52 · see citing works
Tuberculosis endotypes to guide stratified host-directed therapy
DiNardo, A. R., Nishiguchi, T., Grimm, S. L., Schlesinger, L. S., Graviss, E. A., Cirillo, J. D., Coarfa, C., Mandalakas, A. M., Heyckendorf, J., Kaufmann, S. H. E., et al. (2021) · Med · doi:10.1016/j.medj.2020.11.003 · Cited by 46 · see citing works
Engineering Next-Generation CAR-T Cells: Overcoming Tumor Hypoxia and Metabolism
Gao, T. A., & Chen, Y. Y. (2022) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-092120-092914 · Cited by 41 · see citing works
CAR-T cell persistence in the treatment of leukemia and lymphoma
Gupta, A., & Gill, S. I. (2021) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2021.1913146 · Cited by 28 · see citing works
The role of small molecules in cell and gene therapy
Brayshaw, L. L., Martinez-Fleites, C., Athanasopoulos, T., Southgate, T. D., Jespers, L. S., & Herring, C. (2020) · RSC Medicinal Chemistry · doi:10.1039/d0md00221f · Cited by 20 · see citing works
Roddie, C., Dias, J., O'Reilly, M. A., Abbasian, M., Cadiñanos-Garai, A., Vispute, K., Bosshard‐Carter, L., Mitsikakou, M., Charalambous, E., Mehra, V., et al. (2025) · Blood · doi:10.1182/blood.2025028790 · Cited by 12 · see citing works
Solid Tumor Microenvironment Can Harbor and Support Functional Properties of Memory T Cells
Sullivan, P. M., Reed, S. J., Kalia, V., & Sarkar, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.706150 · Cited by 12 · see citing works
“As strategies emerge to control the expression of CARs (29, 34) as well as modulate TCR/CAR signaling (28, 60, 61), our findings reinforce the potential for strategies to mitigate T cell exhaustion in the TME by regulating TCR/CAR expression and/or signaling, thereby augmenting the therapeutic efficacy of adoptive T c…”
ResultLamarche, C., Novakovsky, G., Qi, C. N., Weber, E. W., Mackall, C. L., & Levings, M. K. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.27.175158 · Cited by 10 · see citing works
“This state of functional exhaustion can be manipulated by limiting activity of signaling pathways, and altering the epigenetic program and/or metabolic pathways (Chen et al., 2019; Fraietta et al., 2018; Lynn et al., 2019; Weber et al., 2020b).”
BackgroundInfluentialSelf-citationBenhenda, M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.07.939033
“One reason of failure is T cell dysfunction, due to T cell exhaustion [2, 7, 8].”
Background
- Authors
- Weber, E. W., Lynn, R. C., Parker, K. R., Anbunathan, H., Lattin, J., Sotillo, E., Good, Z., Malipatlolla, M., Xu, P., Vandris, P., Majzner, R. G., Qi, Y., Chen, L.-C., Gentles, A. J., Wandless, T. J., Satpathy, A. T., Chang, H. Y., & Mackall, C. L.
- Affiliations
- Stanford Medicine (US)
- Parker Institute for Cancer Immunotherapy (US)
- Stanford University (US)
- Corresponding author
- Mackall, Crystal L.
- ORCID
- Venue
- bioRxiv (Cold Spring Harbor Laboratory)
- Publisher
- openRxiv
- Published
- 2020-01-27
- OpenAlex
- W3003116639
- Cited by
- 18
- References
- 92
- Citations by year
- 2025: 1 · 2022: 2 · 2021: 9 · 2020: 6
- Type
- posted content
- Language
- en
- Open access
- green
- doi.org
- Licence
- Locations
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- Funders
- Howard Hughes Medical Institute
- Parker Institute for Cancer Immunotherapy
- Human Vaccines Project
- National Institutes of Health (AI 07290)
- Stand Up To Cancer (SU2CAACR-DT1113)
- National Cancer Institute (K08CA230188, SU2CAACR-DT1113, U54CA232568)
- National Institute of Allergy and Infectious Diseases (AI 07290, T32AI007290)
- Topics
- Health Sciences › Medicine › Oncology › CAR-T cell therapy research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- T cell exhaustion, chimeric antigen receptor T cells, epigenetic remodeling, dasatinib, Src kinase inhibition, TCF1, LEF1, antitumor immunity, transcriptional reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review